Most influential people in biopharma—the CEOs
With great pleasure, the Fierce Biotech and Fierce Pharma teams bring you our 2022 selections for the most influential people in biopharma.
Starting today and for the following three weeks, we’ll release five honorees each Monday and tell you their stories. We will shed light on why they are significant players in their respective fields and why their peers are paying close attention to their moves.
In all, the 20 honorees span the gamut of game-changing CEOs—featured today—plus influential scientists, entrepreneurs and regulatory experts.
Arriving at this list of 20 biopharma giants was no easy feat. We solicited reader nominations for months and asked the team of Fierce writers and editors for their own nominations. We've included people representing small companies along with those in Big Pharma, plus people not directly working at a drugmaker but who have outsized influence on the industry.
For today, please enjoy reading about the five game-changing CEOs we selected. With names that are recognizable throughout the industry, readers will likely know part of their stories. But there’s always more beyond the surface, and we hope you gain a new perspective on these CEOs and the other influencers we will showcase in the coming weeks.
Albert Bourla, Pfizer
The chief executives of Big
